| The Anderson study on the effect of chromium supplementation on the biomarkers of type 2 diabetes is the largest single double-blinded randomly controlled trial of the effect of this element on the glucose metabolism of this disorder. This was a well designed and powered study that concluded that chromium, in the form of picolinate, led to improvements in glycaemic control in type 2 diabetics, an effect that was both significant and dose dependent. |